selectION Therapeutics
Germany - Planegg-Martinsried
Biotechnology1 H-1B visas (FY2023)Focus: Highly selective peptide blockers for ion channels
selectION Therapeutics is a life sciences company focused on Highly selective peptide blockers for ion channels.
Immunology
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
Pipeline & Clinical Trials
si-544
Psoriasis VulgarisClinical Trials (1)
NCT06191042A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
Phase 1si-544
Atopic DermatitisClinical Trials (1)
NCT05383378A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
Phase 1Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2010
Portfolio: 2 clinical trials
H-1B (2023): 1 approval
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub